Search hospitals

>

Connecticut

>

Hartford

Hartford Healthcare

Claim this profile

Hartford, Connecticut 06106

Conducts research for Heart Failure

Conducts research for Pancreatic Cancer

Conducts research for Psychotic Episodes

Conducts research for Atrial Fibrillation

Conducts research for Solid Tumors

13 reported clinical trials

0 medical researchers

Photo of Hartford Healthcare in HartfordPhoto of Hartford Healthcare in HartfordPhoto of Hartford Healthcare in Hartford

Summary

Hartford Healthcare is a medical facility located in Hartford, Connecticut. This center is recognized for care of Heart Failure, Pancreatic Cancer, Psychotic Episodes, Atrial Fibrillation, Solid Tumors and other specialties. Hartford Healthcare is involved with conducting 13 clinical trials across 49 conditions. There are 0 research doctors associated with this hospital, such as .

Area of expertise

1

Heart Failure

Hartford Healthcare has run 3 trials for Heart Failure.

2

Pancreatic Cancer

Hartford Healthcare has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Hartford Healthcare

Heart Failure

Pancreatic Cancer

Schizophrenia

Atrial Fibrillation

Hypertrophic Cardiomyopathy

Bipolar disorder

Schizoaffective Disorder

Psychotic Episodes

Deep Vein Thrombosis

Ovarian Cancer

Image of trial facility.

Mavacamten

for Hypertrophic Cardiomyopathy

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructive hypertrophic cardiomyopathy (HCM) who are receiving mavacamten, receiving other treatment for obstructive HCM, or not receiving treatment for obstructive HCM due to intolerance or failure of prior treatment. United States Sub-Study: The purpose of this study is to evaluate the safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting. Europe Sub-Study: The purpose of this study is to evaluate the effectiveness and safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting.

Recruiting

1 award

N/A

10 criteria

Image of trial facility.

Mental Stress

for Heart Failure

The purpose of this study is to investigate whether acute stress can precipitate congestive heart failure (CHF) exacerbation in patients with CHF.

Recruiting

1 award

N/A

1 criteria

Image of trial facility.

CCM Therapy

for Heart Failure

This trial tests a device that helps the heart pump better in patients with moderate heart failure. It targets those whose heart's pumping ability is moderately reduced. The device works by giving the heart small electrical boosts. Several new devices for the treatment of heart failure patients have been introduced and are increasingly used in medical practice or are under evaluation.

Recruiting

0 awards

N/A

7 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Hartford Healthcare?